Liraglutide 3.0mg (Saxenda©) for weight loss: a retrospective real-world clinical evaluation of effectiveness over 12 months among pre Bariatric Surgery patients

被引：0
|
作者：
Wilmington, Rebekah [1 ]
Ardavani, Arash [1 ]
Simenacz, Amelia [1 ]
Green, Carol [2 ]
Idris, Iskandar [1 ]
机构：
[1] Univ Nottingham, Derby, England
[2] Royal Derby Hosp, Derby, England
来源：
OBESITY SURGERY | 2023年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S133 / S133
页数：1
相关论文
共 41 条
  • [1] Liraglutide 3.0 mg (Saxenda©) for Weight Loss and Remission of Pre-Diabetes. Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery
    Rebekah Wilmington
    Arash Ardavani
    Amelia Simenacz
    Carol Green
    Iskandar Idris
    Obesity Surgery, 2024, 34 : 286 - 289
  • [2] Liraglutide 3.0 mg (Saxenda©) for Weight Loss and Remission of Pre-Diabetes. Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery
    Wilmington, Rebekah
    Ardavani, Arash
    Simenacz, Amelia
    Green, Carol
    Idris, Iskandar
    OBESITY SURGERY, 2024, 34 (01) : 286 - 289
  • [3] Liraglutide 3.0 (Saxenda) in bariatric patients: a retrospective real-world clinical evaluation of effectiveness
    Simenacz, Amelia
    Wilmington, Rebekah
    Green, Carol
    Ardavani, Arash
    Idris, Iskandar
    BRITISH JOURNAL OF DIABETES, 2022, 22 (02): : 121 - 124
  • [4] Clinical effectiveness of liraglutide on weight loss in South Koreans First real-world retrospective data on Saxenda in Asia
    Park, Joon Seok
    Kwon, Jieun
    Choi, Hyung Jin
    Lee, Changhyun
    MEDICINE, 2021, 100 (02) : E23780
  • [5] Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
    Wharton, Sean
    Liu, Aiden
    Pakseresht, Arash
    Nortoft, Emil
    Haase, Christiane L.
    Mancini, Johanna
    Power, G. Sarah
    Vanderlelie, Sarah
    Christensen, Rebecca A. G.
    OBESITY, 2019, 27 (06) : 917 - 924
  • [6] REAL-WORLD CLINICAL EFFECTIVENESS OF LIRAGLUTIDE 3.0 MG FOR WEIGHT MANAGEMENT IN CANADA
    Wharton, S.
    Liu, A.
    Pakseresht, A.
    Nortoft, E.
    Haase, C. L.
    Mancini, J.
    Power, G. S.
    VanderLelie, S.
    Christensen, R. A.
    VALUE IN HEALTH, 2018, 21 : S246 - S246
  • [7] Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real-world effectiveness study in Canada
    Wharton, Sean
    Haase, Christiane L.
    Kamran, Elham
    Liu Aiden
    Mancini, Johanna
    Neish, Drew
    Pakseresht, Arash
    Power, G. Sarah
    Christensen, Rebecca A. G.
    OBESITY SCIENCE & PRACTICE, 2020, 6 (04): : 439 - 444
  • [8] Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
    Muratori, Fabrizio
    Vignati, F.
    Di Sacco, G.
    Gavazzi, L.
    Pellegrino, D.
    Del Prete, M.
    EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2022, 27 (07) : 2775 - 2781
  • [9] Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
    Fabrizio Muratori
    F. Vignati
    G. Di Sacco
    L. Gavazzi
    D. Pellegrino
    M. Del Prete
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2022, 27 : 2775 - 2781
  • [10] Long-term weight outcomes in patients treated with liraglutide 3.0 mg in real-world clinical practice
    Grannell, Andrew
    Al-Najim, Werd
    le Roux, Carel
    CLINICAL OBESITY, 2023,
12345